Yonsei Med J.  2009 Feb;50(1):31-38. 10.3349/ymj.2009.50.1.31.

Long-Term Tea Intake is Associated with Reduced Prevalence of (Type 2) Diabetes Mellitus among Elderly People from Mediterranean Islands: MEDIS Epidemiological Study

• Panagiotakos DB
• Lionis C
• Zeimbekis
• Gelastopoulou K
• Papairakleous N
• Das UN
• Polychronopoulos E

• KMID: 1782964
• DOI: http://doi.org/10.3349/ymj.2009.50.1.31

Abstract

PURPOSE: We sought to evaluate the link between long-term tea intake and prevalence of type 2 diabetes mellitus, in a sample of elderly adults.
MATERIALS AND METHODS
During 2005-2007, 300 men and women from Cyprus, 142 from Mitilini, 100 from Samothraki, 114 from Kefalonia, 131 from Crete, 150 from Corfu and 103 from Zakynthos (aged 65 to 100 years) were enrolled. Dietary habits (including tea consumption) were assessed through a food frequency questionnaire. Among various factors, fasting blood glucose was measured and prevalence of (type 2) diabetes mellitus was estimated.
RESULTS
54% of the participants reported that they consume tea at least once a week (mean intake 1.6 +/- 1.1 cup/day). The majority of the participants (98%) reported green or black tea consumption. The participants reported that they consume tea for at least 30 years of their life. After adjusting for various confounders, tea intake was inversely associated with lower blood glucose levels (b +/- SEM per 1 cup: - 5.9 +/- 2.6 mg/dL, p = 0.02). Moreover, multiple logistic regression revealed that moderate tea consumption (1 - 2 cups/day) was associated with 70% (95% CI 41% to 86%) lower odds of having (type 2) diabetes, irrespective of age, sex, body mass, smoking, physical activity status, dietary habits and other clinical characteristics.
CONCLUSION
The presented findings suggest that long-term tea intake is associated with reduced levels of fasting blood glucose and lower prevalence of diabetes, in a cohort of elderly people living in Mediterranean islands.

Keyword

Diabetes; cardiovascular risk factors; tea; elderly

MeSH Terms

Aged
Aged, 80 and over
Cardiovascular Diseases/epidemiology
Cross-Sectional Studies
Cyprus/epidemiology
Diabetes Mellitus, Type 2/*epidemiology
Diet Records
Female
*Food Habits
Humans
Logistic Models
Male
Prevalence
Risk Factors
Sex Distribution
*Tea

Reference

1. Cabrera C, Artacho R, Giménez R. Beneficial effects of green tea-a review. J Am Coll Nutr. 2006. 25:79–99.

2. Japanese Green Tea Online.com. Accessed on 30 December 2008. Available from: URL: http://www.japanesegreenteaonline.com.

3. Weisburger JH. Approaches for chronic disease prevention based on current understanding of underlying mechanisms. Am J Clin Nutr. 2000. 71:6 Suppl. 1710S–1714S. discussion 1715S-9S.

4. Crespy V, Williamson G. A review of the health effects of green tea catechins in in-vivo animal models. J Nutr. 2004. 134:12 Suppl. 3431S–3440S.

5. Sato T, Miyata G. The nutraceutical benefit, part I: green tea. Nutrition. 2000. 16:315–317.

6. Wiseman S, Mulder T, Rietveld A. Tea flavonoids: bioavailability in vivo and effects on cell signaling pathways in vitro. Antioxid Redox Signal. 2001. 3:1009–1021.

7. Higdon JV, Frei B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr. 2003. 43:89–143.

8. Heber D. Vegetables, fruits and phytoestrogens in the prevention of diseases. J Postgrad Med. 2004. 50:145–149.

9. Sueoka N, Suganuma M, Sueoka E, Okabe S, Matsuyama S, Imai K, et al. A new function of green tea: prevention of lifestyle-related diseases. Ann N Y Acad Sci. 2001. 928:274–280.

10. Zaveri NT. Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications. Life Sci. 2006. 78:2073–2080.

11. Koo MW, Cho CH. Pharmacological effects of green tea on the gastrointestinal system. Eur J Pharmacol. 2004. 500:177–185.

12. Yang YC, Lu FH, Wu JS, Wu CH, Chang CJ. The protective effect of habitual tea consumption on hypertension. Arch Intern Med. 2004. 164:1534–1540.

13. Fukino Y, Shimbo M, Aoki N, Okubo T, Iso H. Randomized controlled trial for an effect of green tea consumption on insulin resistance and inflammation markers. J Nutr Sci Vitaminol (Tokyo). 2005. 51:335–342.

14. Tsuneki H, Ishizuka M, Terasawa M, Wu JB, Sasaoka T, Kimura I. Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans. BMC Pharmacol. 2004. 4:18.

15. Meydani M. Nutrition interventions in aging and age-associated disease. Ann N Y Acad Sci. 2001. 928:226–235.

16. Polychronopoulos E, Panagiotakos DB, Polystipioti A. Diet, lifestyle factors and hypercholesterolemia in elderly men and women from Cyprus. Lipids Health Dis. 2005. 4:17.

17. Panagiotakos DB, Kourlaba G, Zeimbekis A, Toutouzas P, Polychronopoulos E. The J-shape association of alcohol consumption on blood pressure levels, in elderly people from Mediterranean Islands (MEDIS epidemiological study). J Hum Hypertens. 2007. 21:585–587.

18. Panagiotakos DB, Pitsavos C, Stefanadis C. Dietary patterns: a Mediterranean diet score and its relation to clinical and biological makers of cardiovascular disease risk. Nutr Metab Cardiovasc Dis. 2006. 16:559–568.

19. Panagiotakos DB, Pitsavos C, Arvaniti F, Stefanadis C. Adherence to the Mediterranean food pattern predicts the prevalence of hypertension, hypercholesterolemia, diabetes and obesity, among healthy adults; the accuracy of the MedDietScore. Prev Med. 2007. 44:335–340.

20. Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003. 35:1381–1395.

21. Iso H, Date C, Wakai K, Fukui M, Tamakoshi A. JACC Study Group. The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Ann Intern Med. 2006. 144:554–562.

22. Cabrera C, Artacho R, Giménez R. Beneficial effects of green tea--a review. J Am Coll Nutr. 2006. 25:79–99.

23. Zang M, Xu S, Maitland-Toolan KA, Zuccollo A, Hou X, Jiang B, et al. Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes. 2006. 55:2180–2191.

24. Waltner-Law ME, Wang XL, Law BK, Hall RK, Nawano M, Granner DK. Epigallocatechin gallate, a constituent of green tea, depresses hepatic glucose production. J Biol Chem. 2002. 277:34933–34940.

25. Vlachopoulos C, Alexopoulos N, Dima I, Aznaouridis K, Andreadou I, Stefanadis C. Acute effect of black and green tea on aortic stiffness and wave reflections. J Am Coll Nutr. 2006. 25:216–223.

26. Janle EM, Portocarrero C, Zhu Y, Zhou Q. Effect of long-term oral administration of green tea extract on weight gain and glucose tolerance in Zucker diabetic (ZDF) rats. J Herb Pharmacother. 2005. 5:55–65.

27. Stangl V, Lorenz M, Stangl K. The role of tea and tea flavonoids in cardiovascular health. Mol Nutr Food Res. 2006. 50:218–228.

28. Cheng TO. Is green tea better than black tea in reducing atherosclerosis? Circulation. 2004. 110:e332.